Plasma Fractionation Market Size Worth $57.54 Billion By 2034 | CAGR: 6.8%

The global plasma fractionation market size is expected to reach USD 57.54 billion by 2034, according to a new study by Polaris Market Research. The report “Plasma Fractionation Market Share, Size, Trends, Industry Analysis Report, By Product (Albumin, Immunoglobulins); By Method (Centrifugation, Depth Filtration); By Application; By End-Use; By Region; Segment Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

Plasma fractionation is a method of separating plasma derivatives. There are many blood collection facilities around the world, and new advancements in technology are increasing the collection of blood plasma. Increasing government initiatives and funding for biotechnology and pharmaceutical R&D are expected to boost industry growth.

As the R&D in the pharmaceutical & biotechnology sectors is growing concerning plasma treatments, the market is anticipated to grow. The outbreak of the COVID-19 pandemic had negatively impacted the market. Worldwide lockdown and stringent regulation had affected the health systems worldwide, including blood donation and supply as well as clinical transfusion management.

Plasma Fractionation Market Report Highlights

• Oncology segment is expected to grow at a higher rate during the forecast period with the increasing prevalence of cancer and the use of therapy in treatment
• The centrifugation segment accounted for the highest revenue share in 2025 and is expected to continue its dominance owing to the high-quality blood supernatant that we get through the centrifugation process.
• Hospitals & clinics segment is expected to continue its dominance during the forecast period. With improved infrastructure and technologically advanced healthcare services, the demand is rising.
• Asia Pacific is expected to grow at a significant rate during the forecast period owing to the increasing geriatric population as well as rising investment in R&D.
• Major players operating in the industry include Grifols, S.A., Shire, Octapharma AG, Kedrion S.P.A, LFB, Biotest AG, Sanquin, China Biologic Products Holdings Inc., GC Pharma, Bio Products Ltd., Japan Blood Products Organization, Emergent BioSolutions, Shanghai Raas Blood Products Co., Ltd., Intas Pharmaceuticals Ltd., Bharat Serum Vaccines Limited

Where is Plasma Fractionation Market Headed?

Demand for immunoglobulin therapies, clotting factors, and albumin products is rising with aging populations and increasing chronic/rare disease prevalence. This factor will boost the market growth in the coming years. Also, technological advancements such as nanofiltration, chromatography, automation, and AI-driven processing are increasingly used to boost yield, safety, and scalability of plasma fractionation and product manufacture. Expansion of plasma collection networks and emerging markets like Asia Pacific will offer significant growth potential. There are also lucrative opportunities in specialty and hyperimmune products targeting specific indications and pandemic preparedness. Recombinant alternatives and streamlined regulatory pathways could widen treatment options. It will prompt strategic innovation and portfolio diversification for industry players.

What Plasma Fractionation Report Reveals?

• What is the global market size, growth trend, and CAGR for the market through 2034?
• What are the market drivers, opportunities, and restraints of the market growth?
• Who are the key players, and what is their relative position in terms of competitive positioning?
• How does the demand for products influence the market landscape?
• How does the market differ in product, application, method, end-use, and geography, and which is the leading end use?
• What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?

Request a free sample copy or read the full market insights :  Plasma Fractionation Market Report

Polaris Market Research has segmented the Plasma Fractionation market report based on product, application, method, end-use, and region:

By Product Outlook (Revenue – USD Billion, 2021–2034)

• Albumin
• Immunoglobulins
• Coagulation Factors
• Protease Inhibitors
• Others

By Application Outlook (Revenue – USD Billion, 2021–2034)

• Neurology
• Hematology
• Oncology
• Immunology
• Pulmonology
• Others

By Method Outlook  (Revenue – USD Billion, 2021–2034)

• Centrifugation
• Depth Filtration
• Chromatography
• Others

By End-Use Outlook (Revenue – USD Billion, 2021–2034)

• Hospitals & Clinics
• Clinical Research
• Others

By Regional Outlook (Revenue – USD Billion, 2021–2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa